LivaNova PLC OCI, before Reclassifications, before Tax, Attributable to Parent
LivaNova PLC (LIVN) reported OCI, before Reclassifications, before Tax, Attributable to Parent of -$52.29 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent · last filed 2025-02-25
- LivaNova PLC oci, before reclassifications, before tax, attributable to parent for the quarter ending 2024-06-30 was -$7.61M, a 239.61% decline year-over-year.
- LivaNova PLC oci, before reclassifications, before tax, attributable to parent for the quarter ending 2024-03-31 was -$17.32M, a 327.34% decline year-over-year.
- LivaNova PLC oci, before reclassifications, before tax, attributable to parent for the quarter ending 2023-12-31 was $26.92M, a 31.52% decline year-over-year.
- LivaNova PLC oci, before reclassifications, before tax, attributable to parent for the quarter ending 2023-09-30 was -$19.22M.
- LivaNova PLC oci, before reclassifications, before tax, attributable to parent for fiscal 2024 was -$52.29M, a 351.76% decline from fiscal 2023.
- LivaNova PLC oci, before reclassifications, before tax, attributable to parent for fiscal 2023 was $20.77M.
- LivaNova PLC oci, before reclassifications, before tax, attributable to parent for fiscal 2022 was -$46.54M.
- LivaNova PLC oci, before reclassifications, before tax, attributable to parent for fiscal 2021 was -$35.64M, a 175.65% decline from fiscal 2020.
| Period end | OCI, before Reclassifications, before Tax, Attributable to Parent 3 month | OCI, before Reclassifications, before Tax, Attributable to Parent 6 month | OCI, before Reclassifications, before Tax, Attributable to Parent 9 month | OCI, before Reclassifications, before Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$52.29M 10-K · filed 2025-02-25 | |||
| 2024-06-30 | -$7.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$24.94M 10-Q · filed 2024-08-01 | $1.98M derived: sum of 3 quarters · filed 2025-02-25 | -$17.24M derived: sum of 4 quarters · filed 2025-02-25 |
| 2024-03-31 | -$17.32M 10-Q · filed 2024-05-03 | $9.60M derived: sum of 2 quarters · filed 2025-02-25 | -$9.63M derived: sum of 3 quarters · filed 2025-02-25 | -$4.17M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-12-31 | $26.92M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $7.70M derived: sum of 2 quarters · filed 2025-02-25 | $13.15M derived: sum of 3 quarters · filed 2025-02-25 | $20.77M 10-K · filed 2025-02-25 |
| 2023-09-30 | -$19.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$13.77M derived: sum of 2 quarters · filed 2024-10-31 | -$6.15M 10-Q · filed 2024-10-31 | $33.16M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $5.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $13.07M 10-Q · filed 2024-08-01 | $52.38M derived: sum of 3 quarters · filed 2025-02-25 | $14.06M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $7.62M 10-Q · filed 2024-05-03 | $46.93M derived: sum of 2 quarters · filed 2025-02-25 | $8.60M derived: sum of 3 quarters · filed 2025-02-25 | -$30.02M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $39.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $983.00K derived: sum of 2 quarters · filed 2025-02-25 | -$37.64M derived: sum of 3 quarters · filed 2025-02-25 | -$46.54M 10-K · filed 2025-02-25 |
| 2022-09-30 | -$38.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$76.94M derived: sum of 2 quarters · filed 2023-11-01 | -$85.85M 10-Q · filed 2023-11-01 | -$95.64M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$38.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | -$47.52M 10-Q · filed 2023-07-26 | -$57.32M derived: sum of 3 quarters · filed 2024-02-29 | -$76.79M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$8.90M 10-Q · filed 2023-05-03 | -$18.70M derived: sum of 2 quarters · filed 2024-02-29 | -$38.17M derived: sum of 3 quarters · filed 2024-02-29 | -$17.52M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$9.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$29.27M derived: sum of 2 quarters · filed 2024-02-29 | -$8.62M derived: sum of 3 quarters · filed 2024-02-29 | -$35.64M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$19.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $1.17M derived: sum of 2 quarters · filed 2022-11-02 | -$25.85M 10-Q · filed 2022-11-02 | $12.63M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $20.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$6.37M 10-Q · filed 2022-08-03 | $32.10M derived: sum of 3 quarters · filed 2023-02-27 | $57.04M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | -$27.02M 10-Q · filed 2022-05-04 | $11.46M derived: sum of 2 quarters · filed 2023-02-27 | $36.40M derived: sum of 3 quarters · filed 2023-02-27 | $54.28M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $38.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $63.42M derived: sum of 2 quarters · filed 2023-02-27 | $81.30M derived: sum of 3 quarters · filed 2023-02-27 | $47.12M 10-K · filed 2023-02-27 |
| 2020-09-30 | $24.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $42.82M derived: sum of 2 quarters · filed 2021-11-03 | $8.64M 10-Q · filed 2021-11-03 | $30.72M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $17.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | -$16.30M 10-Q · filed 2021-07-28 | $5.78M derived: sum of 3 quarters · filed 2022-03-01 | -$22.68M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$34.18M 10-Q · filed 2021-04-28 | -$12.10M derived: sum of 2 quarters · filed 2022-03-01 | -$40.56M derived: sum of 3 quarters · filed 2022-03-01 | -$24.88M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $22.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$6.38M derived: sum of 2 quarters · filed 2022-03-01 | $9.30M derived: sum of 3 quarters · filed 2022-03-01 | $6.38M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$28.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$12.78M derived: sum of 2 quarters · filed 2020-10-29 | -$15.70M 10-Q · filed 2020-10-29 | -$49.00M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $15.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $12.77M 10-Q · filed 2020-07-29 | -$20.54M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2019-03-31 | -$2.92M 10-Q · filed 2020-04-30 | -$36.23M derived: sum of 2 quarters · filed 2021-03-01 | ||
| 2018-12-31 | -$33.31M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$69.72M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | -$36.41M 10-Q · filed 2019-10-30 | |||
| 2017-12-31 | $108.48M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |